BioCentury
ARTICLE | Financial News

Immunovaccine Inc. proposes private placement

November 4, 2013 8:00 AM UTC

Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date announced: 10/28/13 Type: Private placement To be raised: At least C$3.2 million ($3.1 million) Shares: 8 million...